REX American Resources Co... (REX)
NYSE: REX
· Real-Time Price · USD
40.21
0.49 (1.23%)
At close: May 01, 2025, 3:59 PM
40.10
-0.27%
After-hours: May 01, 2025, 05:46 PM EDT
Company Description
REX American Resources Corporation, together with its subsidiaries, produces and sells ethanol in the United States.
The company also offers corn, distillers grains, non-food grade corn oil, gasoline, and natural gas.
In addition, the company provides dry distillers grains with solubles, which is used as a protein in animal feed.
The company was formerly known as REX Stores Corporation and changed its name to REX American Resources Corporation in 2010.
REX American Resources Corporation was founded in 1980 and is headquartered in Dayton, Ohio.
REX American Resources Corporation
| Country | United States |
| IPO Date | Jul 17, 1984 |
| Industry | Chemicals - Specialty |
| Sector | Basic Materials |
| Employees | 122 |
| CEO | Zafar A. Rizvi |
Contact Details
Address: 7720 Paragon Road Dayton, Ohio United States | |
| Website | https://www.rexamerican.com |
Stock Details
| Ticker Symbol | REX |
| Exchange | NYSE |
| Fiscal Year | February - January |
| Reporting Currency | USD |
| CIK Code | 0000744187 |
| CUSIP Number | 761624105 |
| ISIN Number | US7616241052 |
| Employer ID | 31-1095548 |
| SIC Code | 2860 |
Key Executives
| Name | Position |
|---|---|
| Zafar A. Rizvi | Chief Executive Officer, President & Director |
| Douglas L. Bruggeman | Vice President of Finance, Chief Financial Officer & Treasurer |
| Edward M. Kress | Secretary & Director |
| Stuart A. Rose | Executive Chairman & Head of Corporate Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 30, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Apr 28, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Apr 25, 2025 | ARS | Filing |
| Apr 25, 2025 | DEFA14A | Filing |
| Apr 25, 2025 | DEF 14A | Filing |
| Apr 15, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Apr 04, 2025 | 4 | Filing |
| Mar 28, 2025 | 10-K | Annual Report |
| Mar 26, 2025 | 8-K | Current Report |
| Feb 27, 2025 | 4 | Filing |